Effects of Glycine on Collagen, PDGF, and EGF Expression in Model of Oral Mucositis.

Oral mucositis is frequently a toxic effect of chemotherapeutic and/or radiotherapeutic treatment, resulting from complex multifaceted biological events involving DNA damage. The clinical manifestations have a negative impact on the life quality of cancer patients. Preventive measures and curative treatment of mucositis are still not well established. The glycine has anti-inflammatory, immunomodulatory, and cytoprotective actions, being a potential therapeutic in mucositis. The objective was to evaluate the effects of glycine on the expression of collagen and growth factors, platelet and epidermal in a hamster model oral mucositis. The mucositis was induced by the protocol of Sonis. There were 40 hamsters used, divided into two groups: Group I-control; Group II-supplemented with 5% intraperitoneal glycine, 2.0 mg/g diluted in hepes. Histopathological sections were used to perform the immune-histochemical method, the evaluation of collagen expression, and the growth factors: Epidermal growth factor (EGF) and platelet (PDGF). It was observed that the group supplemented with glycine experienced higher amounts of collagen expression and predominance type of collagen I. The glycine group presented lower immunoexpression of the growth factors, EGF and PDGF. The group supplemented with glycine showed a marked healing process of the oral mucosite, demonstrated by the predominance of collagen type I and reduction of growth factors, EGF and PDGF.

A double- blind, randomized, and placebo-controlled clinical trial with omega-3 polyunsaturated fatty acids (OPFA É·-3) for the prevention of migraine in chronic migraine patients using amitriptyline.

OBJECTIVE: To determine the prophylactic effect of OPFAϖ-3 in migraine. SUBJECTS AND METHODS: This was a prospective, experimental, controlled, double-blind, and with comparison groups study. Sixty patients diagnosed with chronic migraine, according to the criteria of the International Classification of Headache Disorders, Third Edition (beta version) (ICHD-3ß), were prophylactically treated with amitriptyline. They were divided into two equal groups: in group 1, prophylaxis was associated with OPFAϖ-3 and in group 2 with placebo. After 60 days, both groups were assessed by a second researcher. RESULTS: Of the 60 patients with chronic migraine, only 51 patients (15 men and 36 women) completed the treatment. The group that received OPFAϖ-3 consisted of 27 (52.9%) patients (six men and 21 women), while the control group was equal to 24 (47.1%) patients (nine men and 15 women). These differences were not significant (χ2 = 1.428; P = 0.375). In 66.7% (18/27) of the patients who used OPFAϖ-3, there was a reduction of more than 80.0% per month in the number of days of headache, while in the control group, the same improvement occurred in 33.3% (8/24) of patients. This difference was significant (χ2 = 5.649; P = 0.036). CONCLUSIONS: Polyunsaturated omega 3 fatty acids (OPFAϖ-3) are useful for prophylaxis of migraine attacks.

Relação entre o consumo de gordura saturada e os fatores de risco cardiovascular em pessoas com síndrome de Down / Relationship between the consumption in fat saturated and cardiovascular risk factors in people with Down syndrome

Objetivo: Avaliar a relação entre o consumo de gordura saturada e o risco cardiovascular em pessoas com síndrome de Down. Estudo transversal, realizado em 33 crianças e adolescentes com síndrome de Down atendidos no Centro Integrado de Educação Especial, de ambos os sexos, com idade entre 3 e 14 anos. Método: Para determinação do estado nutricional, foram utilizadas as curvas específicas. Na avaliação do consumo alimentar foi utilizado o recordatório 24 horas, analisado pelo software "Nutwin", versão 1.5. Para identificação do risco cardiovascular, foram realizadas medidas de circunferências da cintura e pescoço, índice de conicidade, além da pressão arterial. A análise estatística dos dados foi realizada por meio do SPSS v. 18.0, utilizando os testes t de Student, para comparar os valores médios, e a correlação de Pearson, para verificar associação entre as variáveis. Resultados: O indicador P/I revelou excesso de peso para 19,04% do sexo feminino, enquanto que o consumo de gordura saturada esteve inadequado para ambos os sexos, sendo 75% e 85,71%, para meninos e meninas, respectivamente. Quanto ao risco cardiovascular, os valores médios e desvio padrão encontrados para o índice de conicidade foram de 1,02±0,47 e 1,24±0,34 para meninos e meninas, respectivamente, com diferença significativa entre os sexos (p<0,05). Conclusão: Os participantes apresentam risco cardiovascular e a inadequação no consumo de gordura saturada contribui para essa condição.(AU)

Objectives: To evaluate the relationship between the consumption of saturated fat and cardiovascular risk in people with Down syndrome. Cross-sectional study conducted in 33 children and adolescents with Down syndrome seen at Centro Integrado de Educação Especial, of both sexes, aged between 3 and 14 years. Methods: To determine the nutritional status we used the specific curves. In assessing the food intake was used the 24-hour recall, analyzed by software "Nutwin" 1.5 version. To identify cardiovascular risk, waist and neck circumferences, conicity index, as well as blood pressure were measured. Statistical analysis was performed using SPSS v. 18.0 using the t test Student to compare the mean values and the Pearson correlation to verify the association between variables. Results: The P / I indicator revealed excess weight to 19.04% female, while saturated fat intake was inadequate for both sexes, 75% and 85.71% for boys and girls, respectively. As the cardiovascular risk mean values and standard deviation found for conicity index were 1.02±0.47 and 1.24±0.34 for boys and girls, respectively, with a significant difference between the sexes (p<0.05). Conclusion: Participants have cardiovascular risk and inadequate in saturated fat consumption contributes to this condition.(AU)